HSP70 regulates cell proliferation and apoptosis in actinomycin-D-treated lung cancer cells

Kai Zhang1, Ruonan Zhai1, Teng Xue1

  • 1Department of Public Health, Zhengzhou University, Zhengzhou 450052, China.

Abstract

Insights

Heat-shock protein 70 (HSP70) influences lung cancer cell growth and apoptosis. HSP70 activation promotes proliferation and inhibits apoptosis by regulating JNK and p38 MAPK pathways in A549 cells.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Heat-shock protein 70 (HSP70) is implicated in cancer cell apoptosis.
  • The specific role of HSP70 in regulating JNK and p38 MAPK pathways in lung cancer cell growth and apoptosis is not well understood.

Purpose of the Study:

  • To investigate the role of HSP70 in the regulation of JNK and p38 MAPK-dependent growth and apoptosis in lung cancer A549 cells.

Main Methods:

  • In vitro experiments using A549 lung cancer cells.
  • MTT and flow cytometry assays to assess cell proliferation and apoptosis.
  • Manipulation of HSP70 levels via mild heat treatment and siRNA, and assessment of JNK/p38 MAPK pathway activity using Western blot and specific inhibitors (SP600125, SB203580).

Main Results:

  • Mild heat and JNK/p38 MAPK inhibitors promoted cell proliferation and inhibited apoptosis induced by actinomycin D (ActD).
  • HSP70 overexpression decreased p-JNK, p38, and caspase-3 expression, while HSP70 knockdown increased JNK and p38 MAPK expression.
  • HSP70 plays a role in regulating cell growth and apoptosis.

Conclusions:

  • HSP70 is crucial for lung cancer cell growth and apoptosis.
  • HSP70 modulates lung cancer cell behavior through the JNK and p38 MAPK signaling pathways in ActD-treated A549 cells.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.0K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.0K